UNCY EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Unicycive Therapeutics (UNCY) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026

Impact · against what's priced in

The legal reminder for Unicycive Therapeutics serves as a low-impact volatility trigger, as the underlying FDA failures and existing litigation are already reflected in the stock's valuation. There is no material impact on Pentair.

PNR+0.00

Doesn't touch the price's assumptions

The price assumes

Whether the Pool segment inventory destocking is a temporary channel correction